Gene · 1810
Papers3,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancer. | Mol Oncol | 2022 | 35593080 | PubTator, text mining | PubMed |
| Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report. | BMC Nephrol | 2022 | 35581569 | PubTator, text mining | PubMed |
| Molecular characteristics of the full-length genome of occult hepatitis B virus from blood donors in China. | Sci Rep | 2022 | 35581341 | PubTator, text mining | PubMed |
| A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. | Cancer Sci | 2022 | 35579200 | PubTator, text mining | PubMed |
| Doxorubicin impacts chromatin binding of HMGB1, Histone H1 and retinoic acid receptor. | Sci Rep | 2022 | 35577872 | PubTator, text mining | PubMed |
| Macrominerals and Trace Minerals in Commercial Infant Formulas Marketed in Brazil: Compliance With Established Minimum and Maximum Requirements, Label Statements, and Estimated Daily Intake. | Front Nutr | 2022 | 35571960 | PubTator, text mining | PubMed |
| Natural LILRB1 D1-D2 variants show frequency differences in populations and bind to HLA class I with various avidities. | Immunogenetics | 2022 | 35562487 | PubTator, text mining | PubMed |
Interplay between hypertriglyceridemia and acute promyelocytic leukemia mediated by the cooperation of peroxisome proliferator-activated receptor-α with the PML/RAR α fusion protein on super-enhancers. | Haematologica | 2022 | 35546300 | PubTator, text mining | PubMed |
| Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. | Nat Genet | 2022 | 35534562 | PubTator, text mining | PubMed |
| Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2. | Emerg Microbes Infect | 2022 | 35476817 | PubTator, text mining | PubMed |
| Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity. | Front Immunol | 2022 | 35464453 | PubTator, text mining | PubMed |
| Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita. | Front Immunol | 2022 | 35464429 | PubTator, text mining | PubMed |
| A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice. | Cancers (Basel) | 2022 | 35454873 | PubTator, text mining | PubMed |
| Influence Mechanism of Water-Soluble Sodium on Zhundong Coal Pyrolysis. | ACS Omega | 2022 | 35449928 | PubTator, text mining | PubMed |
| The digit ratio (2D:4D) and testosterone co-predict vertical jump performance in athletic boys: Evidence of organizational and activational effects of testosterone on physical fitness. | Physiol Behav | 2022 | 35443197 | PubTator, text mining | PubMed |
| Mechanism of RNA polymerase I selection by transcription factor UAF. | Sci Adv | 2022 | 35442737 | PubTator, text mining | PubMed |
| Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease. | Acta Ophthalmol | 2022 | 35441459 | PubTator, text mining | PubMed |
| Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms. | Nat Commun | 2022 | 35440107 | PubTator, text mining | PubMed |
| Early Blood Transfusion After Kidney Transplantation Does Not Lead to dnDSA Development: The BloodIm Study. | Front Immunol | 2022 | 35432350 | PubTator, text mining | PubMed |
| Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer. | BMC Cancer | 2022 | 35421932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1810/papers?page=20